OncoMark, an AI framework, predicts cancer cell behavior by analyzing internal biological processes, achieving high accuracy. Trained on genetic data, it provides detailed tumor profiles, potentially aiding personalized cancer treatments by “reading the mind of cancer.” Researchers aim to integrate it into clinical practice.